Paid proof
Analytics Debt Ledger
$12,500 fixed scope
Independent review of one critical forecast, dashboard, metric family, AI-generated output, or board-facing number before it drives an executive decision.
Independent forecast and analytics assurance
Forecast Integrity Partners provides independent forecast and analytics assurance for CFOs, CEOs, PE firms, M&A teams, and lenders making capital-critical decisions.
Proven frameworks test forecasts, dashboards, AI-generated analytics, and deal-critical metrics before leadership relies on them.
No software resale. No vendor kickbacks. No implementation bias.
Where to start
Start with the decision risk, not the tool stack.
Paid proof
$12,500 fixed scope
Independent review of one critical forecast, dashboard, metric family, AI-generated output, or board-facing number before it drives an executive decision.
CFO spend review
$25k to $50k
Review for CFOs, CEOs, and boards that need to cut low-value data, BI, cloud, analytics, vendor, or AI spend without weakening decision quality.
PE / M&A
$50k to $100k
Forecast and analytics diligence for PE sponsors, M&A teams, private credit lenders, and corporate development leaders relying on management forecasts or deal-critical metrics.
Buyer-forwardable assets
Before a forecast, dashboard metric, AI-written narrative, or deal-critical figure reaches the board, lender, buyer, or investment committee, test whether it is defensible.
Diagnostic hook
A 10-statement self-assessment for one high-stakes number. It scores source traceability, independent build check, stable definition, grain consistency, forecast drivers, overrides, reconciliation, AI traceability, spend-to-value link, and defensibility under questioning.
Product proof
A redacted sample deliverable showing the review output: engagement at a glance, summary judgment, anomaly ledger, detailed findings, scope, and fixed-scope next step.
Proof stack
The proof page now leads with three real case studies: forecasting built into Tableau, advanced forecast simulations for a $1B+ pharma acquisition, and asset-light international expansion for TV intelligence.
Start small
The first step is routing the risk. Do not send confidential data through the public form.